Search Results for keywords:"best practices"

The Federal Energy Regulatory Commission announced a technical conference to discuss credit risk management in organized wholesale electric markets. This conference, held electronically on February 25 and 26, 2021, featured several panels with experts discussing topics such as credit principles, risk management structures, and the impact of market design on credit risk. The event was open to the public and aimed to explore best practices and potential reforms to enhance credit policies in these markets. Transcripts of the conference were available for purchase from Ace-Federal Reporters, Inc.

The Food and Drug Administration (FDA) has announced the release of a report titled "Food and Drug Administration Report and Plan on Best Practices for Guidance." This report, requested by the Consolidated Appropriations Act, 2023, outlines best practices for creating, prioritizing, and using guidance documents efficiently. The FDA gathered and considered public feedback on a draft report published in December 2023, which led to this final version. The report aims to enhance transparency, improve regulatory processes, and support the development of new products for public health.

The Department of Health and Human Services, through its Office of the Secretary, is seeking public comments on a proposed information collection called the COVID-19 Learning Community Measure. This initiative is part of an effort by the Office of Minority Health to collect data that will help monitor and evaluate the performance of a learning community aimed at responding to COVID-19. They plan to gather quantitative and qualitative data to assess the effectiveness of connecting experts and health leaders, improving networking, and sharing best practices. Comments are due by April 26, 2021, and can be submitted via email or phone to the designated Reports Clearance Officer.

The Food and Drug Administration (FDA) has released a draft report titled "Best Practices for FDA Communication with Interested Parties" and is asking for public feedback. This report is part of a response to the Consolidated Appropriations Act of 2023, which requires the FDA to review and improve its communication methods with medical product sponsors and other external parties. The draft includes current communication practices and explores new, innovative strategies used during the COVID-19 pandemic. People can provide feedback on this draft report until February 3, 2025, through electronic or written submissions.